Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-15-032675

SVP, General Counsel, Sec. sold 1,483 shares at $9.09 ($13,478)

  • SVP, General Counsel, Sec. acquired 4,539 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hadas Nicole R. · SVP, General Counsel, Sec.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-04-01 Grant or award : show line 1 in the form +4,539 $9.51 $43,166 77,576 D
2015-04-02 Sale : show line 2 in the form −1,483 $9.09 $13,478 76,093 D
Open-market sales · 1,483 sh · avg $9.09 · $13,478
Loading xslF345X03/doc4.xml…